Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Joshua Langford

Orthopaedic Surgery Orlando, FL Medical Doctor

NPI 1386771350 CMS profile 62293

1222 S Orange Ave, Orlando, FL 32806

Open in the dashboard

General payments

$407,300

357 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Joshua Langford of Orlando, FL is reported in the CMS Open Payments database as having received $407,300 across 357 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $23,319 40
2024 General $61,491 48
2023 General $60,386 66
2022 General $79,416 46
2021 General $53,450 50
2020 General $43,404 40
2019 General $85,833 67

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joshua Langford
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Joshua Langford were reported at $23,319. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Joshua Langford Orthopaedic Surgery median Middle half National median
2019 $85,833 $644 $140–$2,844 $163
2020 $43,404 $312 $75–$1,860 $114
2021 $53,450 $520 $117–$2,495 $132
2022 $79,416 $598 $128–$2,731 $149
2023 $60,386 $461 $128–$2,264 $160
2024 $61,491 $497 $134–$2,475 $164
2025 $23,319 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $345,720 249 payments
  2. Globus Medical, Inc. $25,654 31 payments
  3. US Implant Solutions, LLC $11,697 12 payments
  4. Arthrex, Inc. $10,576 11 payments
  5. Advanced Orthopaedic Solutions, Inc. $7,102 9 payments
  6. Smith+Nephew, Inc. $4,059 4 payments
  7. Zimmer Biomet Holdings, Inc. $1,413 21 payments
  8. OsteoCentric Technologies, Inc. $173 1 payment
  9. Next Science LLC $163 2 payments
  10. G21 SRL $139 1 payment
  11. Other $602 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $315,295 74 payments
  2. Travel and Lodging $59,134 96 payments
  3. Royalty or License $16,055 15 payments
  4. Food and Beverage $11,464 168 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,850 2 payments
  6. Education $503 2 payments
Products named General payments · program years 2019–2025
  1. T2 Trauma & Extremeties $117,158 63 payments
  2. T2 Trauma & Extremeties $107,321 39 payments
  3. GAMMA Trauma & Extremeties $98,974 33 payments
  4. AXSOS Trauma & Extremeties $66,473 14 payments
  5. HOFFMANN Trauma & Extremeties $44,750 8 payments
  6. PRO $42,779 42 payments
  7. GAMMA Trauma & Extremeties $40,166 17 payments
  8. AXSOS Trauma & Extremeties $32,363 11 payments
  9. VARIAX $22,850 13 payments
  10. HOFFMANN Trauma & Extremeties $22,442 9 payments
  11. Other $162,632 184 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

112

Median for Orthopedic Surgery: 203

Drug cost

$567

Median for Orthopedic Surgery: $1,433

Branded share of claims

47.3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 53 $268
Methocarbamol Generic 25 $162
Ibuprofen Generic 11 $80
Meloxicam Generic 23 $57

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 94 billing codes

Paid by Medicare

$156,600

Medicare's payments for the services billed

Medicare patients

230

Average age 74

Services billed

731

153 women, 77 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 73%
Chronic kidney disease 43%
Ischemic heart disease 40%
Depression 40%
Diabetes 36%
Atrial fibrillation 29%
Heart failure 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

357 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record